CAMP4 Therapeutics Corporation
NASDAQ: CAMP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joshua Mandel-Brehm
- Employees
- 55
- Headquarters
- Cambridge, United States
- IPO year
- 2024
- Market cap
- $85.6M
- Website
- https://www.camp4tx.com
Loading CAMP…
Loading profile data…Frequently asked questions about CAMP
What does CAMP4 Therapeutics Corporation (CAMP) do?
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Where does CAMP trade?
CAMP4 Therapeutics Corporation (CAMP) trades on the NASDAQ Global Market.
What sector is CAMP in?
CAMP4 Therapeutics Corporation (CAMP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CAMP4 Therapeutics Corporation?
Joshua Mandel-Brehm is the chief executive officer of CAMP4 Therapeutics Corporation (CAMP).
Where is CAMP4 Therapeutics Corporation headquartered?
CAMP4 Therapeutics Corporation is headquartered in United States.
Does CAMP pay a dividend?
CAMP4 Therapeutics Corporation (CAMP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CAMP go public?
CAMP4 Therapeutics Corporation (CAMP) completed its initial public offering in 2024.